Literature DB >> 30249394

Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein.

Phelippe Carmo-Gonçalves1, Lucas Alex do Nascimento1, Juliana R Cortines2, David Eliezer3, Luciana Romão4, Cristian Follmer5.   

Abstract

The dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) is believed to play a central role in Parkinson's disease neurodegeneration by stabilizing potentially toxic oligomers of the presynaptic protein α-Synuclein (aSyn). Besides the formation of covalent DOPAL-Lys adducts, DOPAL promotes the oxidation of Met residues of aSyn, which is also a common oxidative post-translational modification found in the protein in vivo. Herein we set out to address the role of Met residues on the oligomerization and neurotoxic properties of DOPAL-modified aSyn. Our data indicate that DOPAL promotes the formation of two distinct types of aSyn oligomers: large and small (dimer and trimers) oligomers, which seem to be generated by independent mechanisms and cannot be interconverted by using denaturing agents. Interestingly, H2O2-treated aSyn monomer, which exhibits all-four Met residues oxidized to Met-sulfoxide, exhibited a reduced ability to form large oligomers upon treatment with DOPAL, with no effect on the population of small oligomers. In this context, triple Met-Val mutant M5V/M116V/M127V exhibited an increased population of large aSyn-DOPAL oligomers in comparison with the wild-type protein. Interestingly, the stabilization of large rather than small oligomers seems to be associated with an enhanced toxicity of DOPAL-aSyn adducts. Collectively, these findings indicate that Met residues may play an important role in modulating both the oligomerization and the neurotoxic properties of DOPAL-derived aSyn species.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DOPAL; Methionine-sulfoxide; Oligomerization; Oxidation: Parkinson's disease; α-Synuclein

Mesh:

Substances:

Year:  2018        PMID: 30249394      PMCID: PMC6293985          DOI: 10.1016/j.bbrc.2018.09.111

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.

Authors:  William J Burke; Vijaya B Kumar; Neeraj Pandey; W Michael Panneton; Qi Gan; Mark W Franko; Mark O'Dell; Shu Wen Li; Yi Pan; Hyung D Chung; James E Galvin
Journal:  Acta Neuropathol       Date:  2007-10-27       Impact factor: 17.088

2.  Robust prediction of the MASCOT score for an improved quality assessment in mass spectrometric proteomics.

Authors:  Thomas Koenig; Bjoern H Menze; Marc Kirchner; Flavio Monigatti; Kenneth C Parker; Thomas Patterson; Judith Jebanathirajah Steen; Fred A Hamprecht; Hanno Steen
Journal:  J Proteome Res       Date:  2008-08-16       Impact factor: 4.466

3.  Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo.

Authors:  Emanuela Colla; Poul H Jensen; Olga Pletnikova; Juan C Troncoso; Charles Glabe; Michael K Lee
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

Review 4.  Methionine oxidation, alpha-synuclein and Parkinson's disease.

Authors:  Charles B Glaser; Ghiam Yamin; Vladimir N Uversky; Anthony L Fink
Journal:  Biochim Biophys Acta       Date:  2004-11-25

5.  α-Synuclein as an intrinsically disordered monomer--fact or artefact?

Authors:  Eduardo Coelho-Cerqueira; Phelippe Carmo-Gonçalves; Anderson Sá Pinheiro; Juliana Cortines; Cristian Follmer
Journal:  FEBS J       Date:  2013-09-02       Impact factor: 5.542

6.  Distance information for disordered proteins from NMR and ESR measurements using paramagnetic spin labels.

Authors:  David Eliezer
Journal:  Methods Mol Biol       Date:  2012

7.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

8.  Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).

Authors:  Cristian Follmer; Eduardo Coelho-Cerqueira; Danilo Y Yatabe-Franco; Gabriel D T Araujo; Anderson S Pinheiro; Gilberto B Domont; David Eliezer
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

9.  Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells.

Authors:  Mordhwaj S Parihar; Arti Parihar; Masayo Fujita; Makoto Hashimoto; Pedram Ghafourifar
Journal:  Int J Biochem Cell Biol       Date:  2009-05-19       Impact factor: 5.085

10.  DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.

Authors:  N Plotegher; G Berti; E Ferrari; I Tessari; M Zanetti; L Lunelli; E Greggio; M Bisaglia; M Veronesi; S Girotto; M Dalla Serra; C Perego; L Casella; L Bubacco
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

View more
  4 in total

1.  Enhanced mitochondrial inhibition by 3,4-dihydroxyphenyl-acetaldehyde (DOPAL)-oligomerized α-synuclein.

Authors:  Theodore A Sarafian; Amneh Yacoub; Anastasia Kunz; Burkan Aranki; Grigor Serobyan; Whitaker Cohn; Julian P Whitelegge; Joseph B Watson
Journal:  J Neurosci Res       Date:  2019-08-16       Impact factor: 4.164

2.  The dopamine receptor agonist apomorphine stabilizes neurotoxic α-synuclein oligomers.

Authors:  Vanderlei de Araujo Lima; Rodrigo Esquinelato; Phelippe Carmo-Gonçalves; Lucas Alex do Nascimento; Hudson Lee; David Eliezer; Luciana Romão; Cristian Follmer
Journal:  FEBS Lett       Date:  2021-12-29       Impact factor: 4.124

3.  Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.

Authors:  Vanderlei de Araújo Lima; Lucas Alex do Nascimento; David Eliezer; Cristian Follmer
Journal:  ACS Chem Neurosci       Date:  2018-11-05       Impact factor: 4.418

4.  Small soluble α-synuclein aggregates are the toxic species in Parkinson's disease.

Authors:  Derya Emin; Yu P Zhang; Evgeniia Lobanova; Alyssa Miller; Xuecong Li; Zengjie Xia; Helen Dakin; Dimitrios I Sideris; Jeff Y L Lam; Rohan T Ranasinghe; Antonina Kouli; Yanyan Zhao; Suman De; Tuomas P J Knowles; Michele Vendruscolo; Francesco S Ruggeri; Franklin I Aigbirhio; Caroline H Williams-Gray; David Klenerman
Journal:  Nat Commun       Date:  2022-09-20       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.